Literature DB >> 18607346

Insulin-like growth factor-1 isoforms in rat hepatocytes and cholangiocytes and their involvement in protection against cholestatic injury.

Manuela Gatto1, Veronica Drudi-Metalli, Alessia Torrice, Gianfranco Alpini, Alfredo Cantafora, Ida Blotta, Domenico Alvaro.   

Abstract

A 'locally acting' IGF1 (insulin-like growth factor 1) isoform has been recently identified in the skeletal muscle and neural tissues where it accelerates injury repair. No information exist on the expression and function of IGF1 isoforms in the liver. We investigated IGF1 isoforms in rat hepatocytes and cholangiocytes and evaluated their involvement in cell proliferation or damage induced by experimental cholestasis (bile duct ligation, BDL) or hydrophobic bile salts. IGF1 isoforms were analyzed by real-time PCR by using beta-actin as internal reference. In both hepatocytes and cholangiocytes, the 'locally acting' IGF1 isoform (XO6108) and 'circulating' IGF1 isoform (NM_178866) represented respectively 44 and 52% of the total IGF1. Basal mRNAs for both 'locally acting' and 'circulating' IGF1 isoforms were higher (P<0.05) in hepatocytes than cholangiocytes. After BDL for 3 h, the 'locally acting' IGF1 isoform decreased threefold (P<0.05) in hepatocytes but remained stable in cholangiocytes with respect to sham-controls. After 1 week of BDL, hepatocytes displayed a further fivefold decrease of 'locally acting' IGF1 mRNA. In contrast, cholangiocytes showed an eightfold increase of the 'locally acting' IGF1 mRNA. The effect of 3 h of BDL on IGF1 isoforms was reproduced in vitro by incubation with glycochenodeoxycholate (GCDC). The cytotoxic effects (inhibition of proliferation and induction of apoptosis) of GCDC on isolated cholangiocytes were more pronounced after selective silencing (SiRNA) of 'locally acting' than 'circulating' IGF1 isoform. Rat hepatocytes and cholangiocytes express the 'locally acting' IGF1 isoform, which decreased during cell damage and increased during cell proliferation. The 'locally acting' IGF1 was more active than the 'circulating' isoform in protecting cholangiocytes from GCDC-induced cytotoxicity. These findings indicate that, besides muscle and neural tissues, also in liver cells the 'locally acting' IGF1 isoform is important in modulating response to damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18607346      PMCID: PMC2569860          DOI: 10.1038/labinvest.2008.63

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  46 in total

1.  Insulin-like growth factor I is a dual effector of multiple myeloma cell growth.

Authors:  N L Ge; S Rudikoff
Journal:  Blood       Date:  2000-10-15       Impact factor: 22.113

2.  Effects of insulin-like growth factor-1 on retinal endothelial cell glucose transport and proliferation.

Authors:  B J DeBosch; E Baur; B K Deo; M Hiraoka; A K Kumagai
Journal:  J Neurochem       Date:  2001-05       Impact factor: 5.372

3.  Insulin-like growth factor-I reverts testicular atrophy in rats with advanced cirrhosis.

Authors:  I Castilla-Cortazar; M Garcia; J Quiroga; N Diez; F Diez-Caballero; A Calvo; M Diaz; J Prieto
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

4.  The histoautoradiographic localization of taurocholate in rat liver after bile duct ligation. Evidence for ongoing secretion and reabsorption processes.

Authors:  H P Buscher; C Miltenberger; S MacNelly; W Gerok
Journal:  J Hepatol       Date:  1989-03       Impact factor: 25.083

Review 5.  Minireview: tissue-specific versus generalized gene targeting of the igf1 and igf1r genes and their roles in insulin-like growth factor physiology.

Authors:  A A Butler; D LeRoith
Journal:  Endocrinology       Date:  2001-05       Impact factor: 4.736

6.  Insulin-like growth factor-1 protects H9c2 cardiac myoblasts from oxidative stress-induced apoptosis via phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways.

Authors:  F Hong; S J Kwon; B S Jhun; S S Kim; J Ha; S J Kim; N W Sohn; C Kang; I Kang
Journal:  Life Sci       Date:  2001-01-26       Impact factor: 5.037

7.  Insulin-like growth factor I is the key growth factor in serum that protects neuroblastoma cells from hyperosmotic-induced apoptosis.

Authors:  C M Van Golen; E L Feldman
Journal:  J Cell Physiol       Date:  2000-01       Impact factor: 6.384

8.  Autocrine signals promote osteoblast survival in culture.

Authors:  A Tumber; M C Meikle; P A Hill
Journal:  J Endocrinol       Date:  2000-12       Impact factor: 4.286

9.  Gastrin inhibits cholangiocyte growth in bile duct-ligated rats by interaction with cholecystokinin-B/Gastrin receptors via D-myo-inositol 1,4,5-triphosphate-, Ca(2+)-, and protein kinase C alpha-dependent mechanisms.

Authors:  S Glaser; A Benedetti; L Marucci; D Alvaro; L Baiocchi; N Kanno; A Caligiuri; J L Phinizy; U Chowdury; E Papa; G LeSage; G Alpini
Journal:  Hepatology       Date:  2000-07       Impact factor: 17.425

10.  Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle.

Authors:  A Musarò; K McCullagh; A Paul; L Houghton; G Dobrowolny; M Molinaro; E R Barton; H L Sweeney; N Rosenthal
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330

View more
  12 in total

1.  MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia.

Authors:  Nicholas J Hand; Amber M Horner; Zankhana R Master; LaTasha A Boateng; Claire LeGuen; Marina Uvaydova; Joshua R Friedman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-02       Impact factor: 2.839

2.  Igf1 expression in mouse model of liver carcinogenesis.

Authors:  L S Zinevich; A S Mikaelyan
Journal:  Dokl Biochem Biophys       Date:  2012-03-15       Impact factor: 0.788

Review 3.  Regulation of biliary proliferation by neuroendocrine factors: implications for the pathogenesis of cholestatic liver diseases.

Authors:  Md Kamruzzaman Munshi; Sally Priester; Eugenio Gaudio; Fuquan Yang; Gianfranco Alpini; Romina Mancinelli; Candace Wise; Fanyn Meng; Antonio Franchitto; Paolo Onori; Shannon S Glaser
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 4.  Autocrine regulation of biliary pathology by activated cholangiocytes.

Authors:  Kendal Jensen; Marco Marzioni; Kamruzzaman Munshi; Syeda Afroze; Gianfranco Alpini; Shannon Glaser
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-22       Impact factor: 4.052

Review 5.  Recent advances in the morphological and functional heterogeneity of the biliary epithelium.

Authors:  Yuyan Han; Shannon Glaser; Fanyin Meng; Heather Francis; Marco Marzioni; Kelly McDaniel; Domenico Alvaro; Julie Venter; Guido Carpino; Paolo Onori; Eugenio Gaudio; Gianfranco Alpini; Antonio Franchitto
Journal:  Exp Biol Med (Maywood)       Date:  2013-05

Review 6.  Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasis.

Authors:  Shannon S Glaser; Paolo Onori; Candace Wise; Fuguan Yang; Marco Marzioni; Domenico Alvaro; Antonio Franchitto; Romina Mancinelli; Gianfranco Alpini; Md Kamruzzaman Munshi; Eugenio Gaudio
Journal:  Dig Liver Dis       Date:  2010-02-13       Impact factor: 4.088

Review 7.  Cholangiocyte proliferation and liver fibrosis.

Authors:  Shannon S Glaser; Eugenio Gaudio; Tim Miller; Domenico Alvaro; Gianfranco Alpini
Journal:  Expert Rev Mol Med       Date:  2009-02-25       Impact factor: 5.600

8.  The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF.

Authors:  M E Behrens; P M Grandgenett; J M Bailey; P K Singh; C-H Yi; F Yu; M A Hollingsworth
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

9.  Growth Hormone Mediates Its Protective Effect in Hepatic Apoptosis through Hnf6.

Authors:  Kewei Wang; Minhua Wang; Maureen Gannon; AiXuan Holterman
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

10.  The role of growth factors on hepatic damage in rats with obstructive jaundice.

Authors:  Ozgur Turk; Bartu Badak; Ersin Ates; Emine Dundar; Emine Sutken
Journal:  Springerplus       Date:  2016-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.